A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease

NCT06826612 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Huntington Disease

Interventions

GENETIC: SPK-10001
OTHER: Placebo Surgery Control

Sponsor

Hoffmann-La Roche